The investment seeks to track the investment results of the MSCI China Small Cap Index... Show more
The iShares MSCI China Small-Cap ETF (ECNS) seeks to track the investment results of the MSCI China Small Cap Index (Net), a benchmark composed of small-capitalization Chinese equities available to international investors. The fund provides targeted, single-country exposure to smaller public companies in China and is frequently used to complement broader China positions or to express a focused view on the small-cap segment.
ECNS holds approximately 252 securities and carries an expense ratio of 0.59%. Its portfolio is concentrated in Health Care (roughly 21%), Industrials, Information Technology, Consumer Discretionary, and Communication, with smaller allocations to Materials, Real Estate, Consumer Staples, and Financials. Among its largest positions are names such as GDS Holdings, Zai Lab, China Everbright Environment Group, Sunac China Holdings, Hutchmed (China), Kingsoft Cloud, Country Garden Services Holdings, Kingboard Holdings, and Chinasoft International. The fund's equity beta relative to the S&P 500 has historically been modest, and its price-to-book and price-to-earnings ratios are relatively low, reflecting the value-oriented profile of the small-cap universe.
The broader environment for Chinese small-cap equities has been shaped by several structural and cyclical forces. Monetary policy remains a key variable, with Chinese authorities balancing growth support against financial-stability concerns, while global interest-rate expectations continue to influence capital flows into emerging-market assets. The property sector, long a cornerstone of Chinese economic activity, has faced persistent deleveraging pressure that weighs on sentiment toward smaller, domestically oriented companies.
Health care and technology — two of the fund's largest exposures — sit at the center of evolving regulatory and competitive dynamics, including drug-pricing policy and efforts to strengthen domestic innovation. Meanwhile, trade tensions and tariff discussions between China and major trading partners add another layer of uncertainty for export-sensitive small caps. For retail investors, small-capitalization equities typically carry higher volatility and lower liquidity than large caps, a characteristic that is amplified in the China market and directly relevant to ECNS as an investment vehicle.
ECNS has drifted modestly lower over recent weeks, with its price movement remaining within a relatively narrow band rather than experiencing a sharp directional move. The fund has traded near the lower portion of its 52-week range, and its year-to-date return has been negative, consistent with broader weakness in Chinese small-cap equities. The gradual nature of the decline — rather than a sudden repricing — points to persistent, structural headwinds rather than an isolated catalyst.
This positioning is closely tied to the performance of its largest sector exposures. Health care holdings have contended with regulatory and pricing dynamics, while real estate and property-related names, including several top holdings, have faced ongoing sector stress. The fund's tilt toward domestically focused small caps also makes it sensitive to consumer confidence, credit conditions, and the pace of any policy easing aimed at stabilizing growth. Because ECNS is a smaller fund with thinner trading volume, its market price can also exhibit wider bid-ask spreads and occasional premiums or discounts relative to net asset value (NAV), the per-share value of the fund's underlying assets.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For investors monitoring funds like ECNS and the broader China small-cap complex, the screener offers a systematic way to evaluate positioning and momentum across sectors and individual names. Explore the AI Screener to refine your own research process.
Looking ahead, several structural factors are likely to shape ECNS through 2026. Macroeconomic growth in China, the trajectory of interest-rate policy both domestically and globally, and inflation trends will remain central to the small-cap equity outlook. The pace and effectiveness of any policy support for the property sector and consumer demand will be critical for the fund's real-estate and consumer-discretionary exposures.
For major holdings, earnings cycles in health care and technology, the pace of innovation, and regulatory developments will influence performance. Capital flows into Chinese equities, the evolution of U.S.-China trade relations, and the competitive landscape among China-focused ETFs may also affect both sentiment and fund-level demand. Risks include heightened volatility, liquidity constraints in small-cap names, and geopolitical developments, while potential catalysts include policy easing, sector stabilization, and a durable recovery in domestic consumption. None of these factors guarantee a specific outcome, but together they define the environment in which ECNS will operate in the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ECNS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 40 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECNS as a result. In 79 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ECNS entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ECNS's RSI Indicator exited the oversold zone, 38 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECNS advanced for three days, in 231 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
ECNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows